期刊
WORLD JOURNAL OF GASTROENTEROLOGY
卷 27, 期 35, 页码 -出版社
BAISHIDENG PUBLISHING GROUP INC
DOI: 10.3748/wjg.v27.i35.5803
关键词
Screening; Nonalcoholic fatty liver disease; Diabetes; Liver fibrosis; Cirrhosis
NAFLD is a common liver disease, especially prevalent in patients with metabolic syndrome and in Western countries. Complications include fibrosis, cirrhosis, hepatocellular carcinoma, as well as increased risk for cardiovascular disease, extrahepatic neoplasia, and other organ damage.
Nonalcoholic fatty liver disease (NAFLD) is becoming a frequent liver disease, especially in patients with metabolic syndrome and especially in Western countries. Complications of NAFLD comprise progressive fibrosis, cirrhosis and hepatocellular carcinoma. NAFLD also represents an independent risk factor for cardiovascular disease, extrahepatic neoplasia and other organ damage, such as renal insufficiency. Given the epidemiological importance of the disease, new developments in specific treatment of the disease and the wide availability of noninvasive techniques in estimating steatosis and fibrosis, NAFLD should be subject to screening programs, at least in countries with a high prevalence of the disease. The review discusses prerequisites for screening, cost-effectiveness, current guideline recommendations, suitability of techniques for screening and propositions for the following questions: Who should be screened? Who should perform screening? How should screening be performed? It is time for a screening program in patients at risk for NAFLD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据